NM_152618.3:c.27_30delCAAA
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_152618.3(BBS12):c.27_30delCAAA(p.Asn9LysfsTer21) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_152618.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BBS12 | NM_152618.3 | c.27_30delCAAA | p.Asn9LysfsTer21 | frameshift_variant | Exon 2 of 2 | ENST00000314218.8 | NP_689831.2 | |
BBS12 | NM_001178007.2 | c.27_30delCAAA | p.Asn9LysfsTer21 | frameshift_variant | Exon 3 of 3 | NP_001171478.1 | ||
BBS12 | XM_011531680.3 | c.27_30delCAAA | p.Asn9LysfsTer21 | frameshift_variant | Exon 2 of 2 | XP_011529982.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BBS12 | ENST00000314218.8 | c.27_30delCAAA | p.Asn9LysfsTer21 | frameshift_variant | Exon 2 of 2 | 1 | NM_152618.3 | ENSP00000319062.3 | ||
BBS12 | ENST00000542236.5 | c.27_30delCAAA | p.Asn9LysfsTer21 | frameshift_variant | Exon 3 of 3 | 2 | ENSP00000438273.1 | |||
BBS12 | ENST00000433287.1 | c.27_30delCAAA | p.Asn9LysfsTer21 | frameshift_variant | Exon 3 of 3 | 2 | ENSP00000398912.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Asn9Lysfs*21) in the BBS12 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 702 amino acid(s) of the BBS12 protein. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with BBS12-related conditions. This variant disrupts the C-terminus of the BBS12 protein. Other variant(s) that disrupt this region (p.Asp687Valfs*3) have been determined to be pathogenic (Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.